Brief: VALBIOTIS Presents Novel Data about TOTUM-63, Metabolic Diseases Prevention

Valbiotis SA

07/06/2019 06:47

June 7 (Reuters) - VALBIOTIS SAS  ALVAL.PA :
    * TOTUM-63 REDUCES INFLAMMATION IN VISCERAL ADIPOSE TISSUE,
ONE OF
MECHANISMS LEADING TO TYPE 2 DIABETES AND METABOLIC DISEASES.
    * THESE RESULTS WERE OBTAINED BY AN INDEPENDENT STUDY LED BY
DR.
BRUNO GUIGAS AT LEIDEN UNIVERSITY (NETHERLANDS)
    * EFFICACY OF TOTUM-63 ON SUGAR AND LIPID METABOLISM IS
CONFIRMED
IN A MURINE MODEL OF PREDIABETES

Source text for Eikon:  ID:nBw776Dfga 
Further company coverage:  ALVAL.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))